Chronic hepatitis C in long term survivors of haematological malignancy treated in a single centre

Journal of Clinical Pathology

Volumn 49, Issue 3, 1996, Pages 230-232

  Neilson, J R ^a   Harrison, P ^a   Skidmore, S J ^b   King, J A ^b   Collingham, K E ^b   Milligan, D W ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b Department of Virology ^*

Author keywords

Bone marrow transplantation; Hepatitis C; Leukaemia

Indexed keywords

ALPHA INTERFERON;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CHRONIC HEPATITIS; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HUMAN; LEUKEMIA; LYMPHOMA; MALE; PRIORITY JOURNAL;

EID: 0030001860     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.3.230     Document Type: Article

References (14)

1. Lee SD, Hwang SJ, Lu RH, Lai KH, Tsai YT, Lo KJ. Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis. J Infect Dis 1991; 163:1354-7.
2. Patel A, Sherlock S, Dusheiko G, Scheuer P, Ellis LA, Ashrafzedeh P. Clinical course and histological correlations in posttransfusion hepatitis C: the Royal Free Hospital Experience. Eur J Gastroenterol Hepatol 1991;3: 491-5.
3. Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, et al. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis C virus contaminated factor VIII concentrates. Lancet 1990;336:1022-5.
4. Vrielink H, van der Poel CL, Reesink HW, Zaaijer HL, Scholten H, Kremer LCM, et al. Look-back study of infectivity of anti-HCV ELISA-positive blood components. Lancet 1995;345:95-6.
5. Mutimer DJ, Harrison RF, O'Donnell KB, Shaw J, Martin BAB, Atrah H, et al. Hepatitis C in asymptomatic British blood donors with indeterminate seropositivity. BMJ 1994;309:847-8.
6. Arico M, Maggiore G, Silini S, Bono F, Viganò C, Cerino A, et al. Hepatitis C infection in children treated for acute lymphoblastic leukaemia. Blood 1994;84:2919-22.
7. Kohlo E, Oksanen K, Honkanen E, Naukkannen R, Krusius T. Hepatitis C antibodies in dialysis patients and patients with leukaemia. J Med Virol 1993;40:318-21.
8. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monte M, Longombardo G, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-4.
9. Alter HJ. Discovery of the non-A, non-B hepatitis virus: the end of the beginning or the beginning of the end. Transfus Med Rev 1989;3:77-81.
10. Murphy MF, Waters AH, Grint PCA, Hardiman AE, Lister TA. Hepatitis C infection in multitransfused patients with acute leukaemia. Lancer 1990;335:58-9.
11. Brink NS, Chopra R, Perrons CJ, Ring CJA, Garson JA, Briggs EM, et al. Acute hepatitis C, infection in patients undergoing therapy for haematological malignancies: a clinical and virological study. Br J Haemotol 1993;83: 498-503.
12. Calman KC. Hepatitis C and blood transfusion look back. PL CMO(95)1. April 1995.
13. Varagona G, Brown D, Kibbler H, Scheuer P, Ashrafzedeh P, Sherlock S, et al. Response, relapse and retreatment rates and viraemia in chronic hepatitis C treated with α2b interferon. A phase III study. Eur J Gastroenterol Hepatol 1992;4:707-12.
14. Bruno S, Rossi S, Petroni ML, Villa E, Zum M, Podda M. Normal aminotransferase concentrations in patients with antibodies to hepatitis C. BMJ 1994;308:697.